Fabrication of programmed photosensitizer-conjugated nanoassemblies by dual supramolecular self-assembly for photodynamic therapy of orthotopic hepatoma

Haitao Hu,Wenbin Dai,Yuhuang Zhang,Yue Huang,Jun Qian,Qiao Jin,Jian Ji,Zhe Tang
DOI: https://doi.org/10.1016/j.cej.2022.134930
IF: 15.1
2022-01-01
Chemical Engineering Journal
Abstract:Supramolecular self-assembly has been extensively adopted as a promising strategy to fabricate nanoassemblies as drug carriers for cancer treatment. In this research, glutathione (GSH) activatable photosensitizer (PS) -conjugated nanoassemblies are fabricated by dual supramolecular self-assembly. Poly(ethylene glycol)-blockpolylysine with pendant benzimidazole (PEG-b-PLys(BM)) is synthesized as the guest molecule of alpha-CD and beta-CD. Chlorin e6 (Ce6) is loaded to the nanocarriers by the formation of polyrotaxanes between Ce6 conjugated alpha-CD (alpha-CD-SS-Ce6) and PEG block of PEG-b-PLys(BM). The Ce6 conjugated nanocarriers are then capped by (2hydroxypropyl)-beta-cyclodextrin (beta-CD-HP) due to the host-guest interaction between beta-CD-HP and benzimidazole (BM) to form supramolecular nanocarriers (BM-Ce6 NPs). BM-Ce6 NPs are negatively charged in physiological environment. However, because of the removal of beta-CD-HP upon the protonation of BM, the surface charge of BM-Ce6 NPs can be converted to positive in acidic tumour microenvironment, which could lead to enhanced cellular internalization. Furthermore, Ce6 can be effectively released and activated in intracellular reductive environment, resulting in stronger reactive oxygen species (ROS) generation capability. The photodynamic therapeutic efficacy of BM-Ce6 NPs is evaluated on subcutaneous and orthotopic hepatoma model on nude mice. This research provides an innovative approach to fabricate drug nanocarriers by dual supramolecular self assembly.
What problem does this paper attempt to address?